Skip to main content
HR 2740 107th Congress House Health Charitable contributions Charities Commerce Drug adulteration Drugs Government Operations and Politics Government paperwork Labeling Packaging Tax-exempt organizations Taxation Transportation and Public Works

Drug Access Act of 2001

Introduced: August 2, 2001 See on congress.gov
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 16, 2001
Referred to the Subcommittee on Health.
Aug 2, 2001
Referred to the House Committee on Energy and Commerce.
Aug 2, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Drug Access Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to authorize a charitable health care entity to receive a drug sample donated by specified individuals or by another such entity for dispensing to a patient of the charitable institution, and to donate a drug sample to another such entity for dispensing to its patients, if: (1) delivery of the sample is completed by mail or common carrier, collection by an authorized agent or employee of the recipient entity, or personal delivery by a licensed practitioner or an agent or employee of the donating entity; (2) the entity receiving the sample executes a written receipt upon its delivery and provides for the return of the receipt to the donating entity; (3) the donated drug sample received by the entity is in its original, unopened packaging with its labeling intact; and (4) before dispensing such sample to a patient, the sample is examined by a licensed practitioner or registered pharmacist to confirm that the sample is not adulterated or misbranded.
What's happening now August 16, 2001

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2740: Drug Access Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2740/
MLA
"H.R. 2740: Drug Access Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2740/.
Bluebook (legal)
H.R. 2740, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2740/.
Markdown link
[H.R. 2740: Drug Access Act of 2001](https://openamerica.io/bill/107-HR-2740/)
Report a problem